Ozempic ® (semaglutide) injection 0.5 mg, 1 mg or 2 mg is a once-weekly glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve blood sugar (glucose), along with diet and exercise ...

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

Case Western Reserve researchers found semaglutide users had significantly lower Alzheimer's-related dementia risk compared ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

By the end of the trial, the semaglutide group spent 6.9% more time in normoglycemia glucose range (70-140 mg/dL), 8.8% longer in target glycemic range (70-180 mg/dL) -- equating to about 2 hours ...

New research finds that men taking a GLP-1 for their obesity or type 2 diabetes often experience a rise in testosterone ...

Novo Nordisk NVO announced that it has submitted a regulatory application to the European Medicines Agency (EMA) seeking ...

Ozempic (semaglutide) and metformin are prescription drugs that are both used to help manage blood sugar levels in people with type 2 diabetes. Ozempic is a brand-name drug, while metformin is a ...